8-K: ModivCare Updates Financials Amid Capital Raise Plans, Cites Receivable Collection Delays
Current Report
ModivCare Inc. files an 8-K to update its financials in anticipation of seeking additional capital, while also disclosing delays in collecting outstanding receivables.
Summary
- ModivCare has filed an 8-K report to update its consolidated financial statements for the years 2021-2023, primarily to add a note regarding events subsequent to the issuance of the financial statements.
- The company is preparing to seek additional capital, including filing a shelf registration statement with the SEC.
- ModivCare is experiencing delays in collecting outstanding contract receivables, despite management's efforts and assurances from customers.
- The company acknowledges the possibility of not achieving full resolution of these receivables in a timely manner or at all due to unforeseen circumstances.
- The updated financials include consolidated balance sheets, statements of operations, statements of cash flows, and statements of stockholders' equity.
- The report should be read in conjunction with the company's annual report on Form 10-K and subsequent quarterly reports.
- The company's cash and cash equivalents were $2.2 million as of December 31, 2023, and it had $375.1 million in accounts, contract, and other receivables.
- ModivCare does not have sufficient cash to repay its Senior Notes due in 2025 and expects to raise additional capital to address this.
Sentiment
Score: 3
Explanation: The document reveals significant financial challenges, including a large net loss, goodwill impairment, and delays in collecting receivables, which are major concerns for investors. The need for a capital raise further underscores the company's financial distress.
Positives
- Management believes it has made substantial progress in reaching oral and written assurances and agreements from its customers related to collecting these outstanding receivables.
- The company continues to pursue collection of outstanding contract receivables for services rendered.
Negatives
- The company is experiencing delays in collecting outstanding contract receivables.
- There is a possibility that the company will not achieve full resolution of receivables in a timely manner or at all.
- The company recorded a significant goodwill impairment charge of $183.1 million in 2023.
- The company's cash and cash equivalents are low at $2.2 million.
- The company reported a net loss of $204.46 million for 2023.
- The company does not have sufficient cash to repay its Senior Notes due in 2025.
Risks
- The company faces the risk of not collecting outstanding receivables in a timely manner, which could impact its financial stability.
- The company may not be able to meet its financial obligations, including repaying its Senior Notes due in 2025, without raising additional capital.
- Failure to meet financial covenants in its debt instruments could cause obligations to become immediately due and payable.
- The company's ability to sustain operations relies heavily on the timely collection of contract receivables and compliance with debt covenants.
- There is no assurance that additional capital will be available when needed on acceptable terms.
Future Outlook
The company expects to raise additional capital to repay or refinance its debt due in 2025 and is taking actions to seek additional capital, including filing a shelf registration statement with the SEC.
Management Comments
- Management believes it has made substantial progress in reaching oral and written assurances and agreements from its customers related to collecting these outstanding receivables.
- Management intends to undertake actions to seek additional capital and take other available measures to further address these issues, support the funding of our operations and improve our liquidity.
Industry Context
The healthcare services industry is facing challenges related to reimbursement and regulatory changes, which are impacting ModivCare's ability to collect receivables. The company's focus on social determinants of health and technology-enabled solutions positions it to address these challenges, but the current financial situation requires immediate action.
Comparison to Industry Standards
- ModivCare's financial performance, particularly the significant net loss and goodwill impairment, is worse than some of its peers in the healthcare services sector.
- Companies like LogistiCare (now part of Carelon) and other large NEMT providers typically have more stable revenue streams and better cash flow management.
- The delays in collecting receivables are unusual for companies with established contracts with government payors, suggesting potential issues with ModivCare's internal processes or contract terms.
- The goodwill impairment indicates that the company may have overpaid for acquisitions or that the acquired businesses are not performing as expected, which is a concern compared to industry standards.
Legal Proceedings
- The company settled an arbitration with its former CEO, Daniel Greenleaf, for $9.6 million.
- The company settled a class action lawsuit related to transportation providers for an undisclosed amount.
- The company is involved in a class action lawsuit related to pay for live-in caregivers, with discovery ongoing.
Related Party Transactions
- In 2021, Coliseum Capital Management, LLC exercised stock option equivalent units for a total cash settlement of $27.8 million.
Stakeholder Impact
- Shareholders face the risk of further dilution due to the potential capital raise.
- Employees may be concerned about the company's financial stability and potential restructuring.
- Customers may be impacted by potential changes in service delivery due to the company's financial challenges.
- Creditors face the risk of non-payment or restructuring of debt.
Next Steps
- The company intends to file a shelf registration statement with the SEC to seek additional capital.
- The company will continue to pursue collection of outstanding contract receivables.
- The company will take other available measures to support the funding of operations and improve liquidity.
Key Dates
| Date | Description |
|---|---|
| February 25, 2022 | Deloitte & Touche LLP report date relating to the financial statements of Mercury Parent, LLC. |
| February 23, 2024 | KPMG LLP report date with respect to the consolidated financial statements and financial statement schedule II of ModivCare Inc. |
| February 26, 2024 | Date of initial filing of the Annual Report on Form 10-K for the year ended December 31, 2023. |
| September 11, 2024 | Date of consent of independent registered public accounting firm by KPMG LLP and Deloitte & Touche LLP. |
| September 12, 2024 | Date of the 8-K report filing. |
Keywords
ModivCare, receivables, capital raise, financial statements, goodwill impairment, debt, healthcare services, NEMT, PCS, RPM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.